Overview
- Legal name
- PFIZER INC
- Registered location
- NEW YORK, NY, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Jun 9, 2026
Read company summary
PFIZER INC is associated with UEI MHBQULRMEEJ5 and CAGE 86491 in public federal records. AcornBids currently links 1,630 prime awards totaling $11.2B in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Biological Product (except Diagnostic) Manufacturing; Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists NEW YORK, NY, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 4, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- PFIZER INC
- UEI
- MHBQULRMEEJ5
- CAGE
- 86491
- Registered address
- 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Aug 11, 2025
- Initial registration
- Jan 30, 2002
- Entity start
- Jun 2, 1942
- SAM updated
- Jul 30, 2026
- Registration expires
- Aug 11, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 1,630 awards and $11,186,614,237 in reported obligations to this legal entity. Source
- Recorded awards include Biological Product (except Diagnostic) Manufacturing (NAICS 325414); this classification is not proof of every company capability. Source
- An example award describes: PFIZER VACCINES STORAGE AND ROTATION CONTRACT Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 1,630 of 1,630 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $-140.2K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $1.4M |
| Change | $-1.6M |
| Growth | -109.7% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Defense | $11.1B | 1625 |
| Department of Health and Human Services | $1.2M | 5 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| W6QK ACC-PICA | $11.1B | 1 |
| CDC OFFICE OF ACQUISITION SERVICES | $2.2M | 1 |
| ASPR/ORM-SNS | $1.7M | 3 |
| DLA TROOP SUPPORT | $741.5K | 2 |
| DLA TROOP SUPPORT | $646.6K | 1622 |
| BARDA - ASPR / DAAPPO / BARDA DCMA | $-2.6M | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | $11.1B | 1 |
| 325412 — Pharmaceutical Preparation Manufacturing | $3.1M | 1627 |
| 493120 — Refrigerated Warehousing and Storage | $2.2M | 1 |
| 541711 | $-2.6M | 1 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $11.1B | 1621 |
| R799 — Other Management Support Services | $2.2M | 1 |
| 6515 — Medical and Surgical Instruments, Equipment, and Supplies | $4 | 7 |
| AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $-2.6M | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $11.1B | 2 |
| 75D30122D14203 | $2.2M | 1 |
| 75A50121A00001 | $1.7M | 2 |
| SPE2D020D0014 | $1.4M | 1624 |
| 36F79724D0130 | $0 | 1 |
States
| Category | Period obligations | Awards |
|---|---|---|
| NY | $11.1B | 1629 |
| Unclassified | $-2.6M | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $11.1B | 4 |
| Unclassified | $3.5M | 1626 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75D30122F00001PFIZER VACCINES STORAGE AND ROTATION CONTRACT | Department of Health and Human Services | $2.2M | Aug 1, 2022 | Jul 31, 2027 |
| SPE2D326F181M4572079776!PREMARIN 25 MG VIALS | Department of Defense | $562 | Jun 9, 2026 | Jun 10, 2026 |
| SPE2D326F182P4572079775!METOCLOPRAMIDE 10 MG/2 ML VIAL 2ML | Department of Defense | $24 | Jun 9, 2026 | Jun 10, 2026 |
| SPE2D326F183G4572089558!LEVOPHED 4 MG/4 ML VIAL 4ML | Department of Defense | $15 | Jun 9, 2026 | Jun 10, 2026 |
| SPE2D326F183K4572082909!DOBUTAMINE 250 MG/20 ML VIAL 20ML | Department of Defense | $42 | Jun 9, 2026 | Jun 10, 2026 |
| SPE2D326F183N4572082908!METOPROLOL TART 5 MG/5 ML VIAL 5ML | Department of Defense | $6 | Jun 9, 2026 | Jun 10, 2026 |
| SPE2D326F171G4572042400!LIDOCAINE HCL 1% VIAL 50ML | Department of Defense | $96 | Jun 5, 2026 | Jun 8, 2026 |
| SPE2D326F171H4572042399!CEFTRIAXONE 1 GM VIALS | Department of Defense | $55 | Jun 5, 2026 | Jun 8, 2026 |
| SPE2D326F171R4572042655!CEFTRIAXONE 1 GM VIALS | Department of Defense | $14 | Jun 5, 2026 | Jun 8, 2026 |
| SPE2D326F171W4572046033!SILVADENE 1% CREAM 400GM | Department of Defense | $109 | Jun 5, 2026 | Jun 8, 2026 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 30, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jan 30, 2002 |
| Entity start | Jun 2, 1942 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| TINA DINDYAL | Government business | Contact method not published | SAM registration | Not available |
| SYLVIA STOBINSKI | Alternate government business | Contact method not published | SAM registration | Not available |
| JOSEPH THOMPSON | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit